BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22667341)

  • 1. Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.
    Deau B; Bachy E; Ribrag V; Delarue R; Rubio MT; Bosq J; Varet B; Brousse N; Hermine O; Canioni D
    Leuk Lymphoma; 2013 Jan; 54(1):41-5. PubMed ID: 22667341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
    Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
    PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.
    Kayal S; Mathur S; Karak AK; Kumar L; Sharma A; Bakhshi S; Raina V
    Leuk Lymphoma; 2014 May; 55(5):1031-7. PubMed ID: 24067108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
    Guo B; Cen H; Tan X; Ke Q
    BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.
    Panico L; Ronconi F; Lepore M; Tenneriello V; Cantore N; Dell'Angelo AC; Ferbo U; Ferrara F
    Leuk Lymphoma; 2013 Nov; 54(11):2418-25. PubMed ID: 23432688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
    Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
    Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.
    Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F
    Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
    Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
    Abd Allah MYY; Fahmi MW; El-Ashwah S
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.
    Agur A; Amir G; Paltiel O; Klein M; Dann EJ; Goldschmidt H; Goldschmidt N
    Leuk Lymphoma; 2015 May; 56(5):1315-9. PubMed ID: 25204373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
    Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ
    Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TIA1 and PAX5 in Classical Hodgkin Lymphoma at Initial Diagnosis May Predict Clinical Outcome.
    Nguyen TT; Frater JL; Klein J; Chen L; Bartlett NL; Foyil KV; Kreisel FH
    Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):383-91. PubMed ID: 26067141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt.
    Mohamed O; El Bastawisy A; Allahlobi N; Abdellateif MS; Zekri ARN; Shaarawy S; Korany Z; Mohanad M; Bahnassy AA
    Diagn Pathol; 2020 Feb; 15(1):10. PubMed ID: 32019558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.
    Hollander P; Rostgaard K; Smedby KE; Molin D; Loskog A; de Nully Brown P; Enblad G; Amini RM; Hjalgrim H; Glimelius I
    Eur J Haematol; 2018 Jan; 100(1):88-97. PubMed ID: 29064587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
    Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
    Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.
    Arlt A; von Bonin F; Rehberg T; Perez-Rubio P; Engelmann JC; Limm K; Reinke S; Dullin C; Sun X; Specht R; Maulhardt M; Linke F; Bunt G; Klapper W; Vockerodt M; Wilting J; Pukrop T; Dettmer K; Gronwald W; Oefner PJ; Spang R; Kube D
    Mol Oncol; 2020 Mar; 14(3):571-589. PubMed ID: 31825135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma.
    Tzankov A; Matter MS; Dirnhofer S
    Pathobiology; 2010; 77(6):301-8. PubMed ID: 21266828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.
    Jakovic LR; Mihaljevic BS; Perunicic Jovanovic MD; Bogdanovic AD; Andjelic BM; Bumbasirevic VZ
    Leuk Lymphoma; 2011 Oct; 52(10):1913-9. PubMed ID: 21663512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.
    Abdou AG; Asaad NY; Loay I; Shabaan M; Badr N
    J Environ Pathol Toxicol Oncol; 2013; 32(4):289-305. PubMed ID: 24579783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.